United Therapeutics Corporation

United Therapeutics Corporation

UTHR
United Therapeutics CorporationUS flagNASDAQ Global Select
548.25
USD
+2.29
- -
23.27BMarket Cap

United Therapeutics Corporation (UTHR) Stock Split History

Learn about United Therapeutics Corporation's most recent 2-for-1 basis stock split on September 23, 2009. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about United Therapeutics Corporation's most recent stock split

Split Date: 2009-09-23
Split Ratio: 2:1
Price Before Split: $95.50
Price After Split: $47.75

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 2.00 times more shares (a 2:1 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of United Therapeutics Corporation's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2009-09-232:1No$95.50$47.75

About United Therapeutics Corporation

Company overview and industry information

United Therapeutics Corporation (UTHR) operates in the Biotechnology industry. The recent 2-for-1 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Biotechnology
Go to United Therapeutics Corporation Summary

Last updated: 6/15/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.